The Broad Institute, established in 2004, is a leading genomic research center affiliated with MIT, Harvard, and several prominent hospitals. Its core mission is to improve human health through basic and translational research in genomics, bioinformatics, and biomedicine. The institute offers contract research services focusing on cell circuits, chemical biology, cancer, psychiatric diseases, and population genetics, serving clients primarily in the United States.
Notable figures associated with the Broad Institute include its director, Todd Golub. The institute has made significant strides in genomic research, including advancements in CRISPR technology and prime editing systems. Its collaborative efforts have accelerated discoveries that impact cancer treatment and understanding of genetic diseases. The Broad Institute's work has had a profound influence on biomedical research, contributing to the development of new therapies and enhancing the scientific community's knowledge base.
Broad Institute
- Company Overview
Operating Status
Active
Ownership Type(s)
Non-profit
Main Product(s)
Genomic Research
Technology
Genomics, Bioinformatics
Tags
Biotech, Data
Broad Institute
- Operating Model
Model Types
Research
Revenue Type(s)
Consulting
Customer Type(s)
Enterprise, Government
Geographic Exposure
United States
Broad Institute - FAQ
When was Broad Institute founded?
Broad Institute was founded in 2003.
Where is Broad Institute's headquarters located?
Broad Institute's headquarters is located in Cambridge, MA, US.
How many employees does Broad Institute have?
Broad Institute has 750 employees as of Feb 5, 2024.
How much has Broad Institute raised to-date?
As of July 05, 2023, Broad Institute has raised a total of $183.3M (USD) since Aug 11, 2020.
Broad Institute - Comparables
Add Comparison
Broad Institute - Fundraising
Total Raised to Date
$183.3M
USD
Last Update Aug 11, 2020
Broad Institute - Employees
Total Employees Over Time
750
As of Feb 2024
Broad Institute - Contact Information
Broad Institute Address
415 Main Street
Cambridge,
Massachusetts
02142-1027
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.